Intrinsic LifeSciences

About:

Intrinsic LifeSciences LLC, a life sciences company, develops in vitro diagnostic devices for clinical medicine applications

Website: http://www.intrinsiclifesciences.com/

Top Investors: National Institutes of Health

Description:

Intrinsic LifeSciences LLC, a life sciences company, develops in vitro diagnostic devices for clinical medicine applications. It focuses on the development of diagnostic tests and biomarker panels for the diagnosis of genetic and acquired iron disorders, including congential anemias, hemochromatosis, and inflammatory diseases in which iron homeostasis is dysregulated. The company also develops biological therapeutics, as well as hepcidin assays for measuring hepcidin; performs hepcidin assays for pharmaceutical companies and clinical investigators worldwide; and provides clinical research services. In addition, it offers hepcidin products, including kits, common reagents, specific reagents, hepcidin murine-compete, mouse hepcidin-1 peptide standard solutions, mouse hepcidin-1 biotin conjugates, sample diluents, SA-HRP conjugates, wash solutions, TMB substrates, and stop solutions online. The company was founded in 2006 and is based in La Jolla, California.

Total Funding Amount:

$4.45M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

La Jolla, California, United States

Founded Date:

2006-01-01

Contact Email:

info(AT)intrinsiclifesciences.com

Founders:

Alex Martinez, Jason D. Ferrone, Mark Westerman, Vaughn Ostland

Number of Employees:

11-50

Last Funding Date:

2014-07-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai